A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells

European Journal of Pharmacology

Volumn 412, Issue 1, 2001, Pages 13-20

  Weber, H Christian ^a   Walters, James ^b   Leyton, Julius ^b   Casibang, Marchessini ^b   Purdom, Sally ^b   Jensen, Robert T ^c   Coy, David H ^d   Ellis, Chad ^b   Clark, Geoffrey ^b   Moody, Terry W ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bombesin receptor subtype 3; c fos mRNA; Elk 1; Lung cancer; Mitogen activated protein kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BOMBESIN 3 RECEPTOR; BOMBESIN DERIVATIVE; BOMBESIN RECEPTOR; BW 2258U89; CALCIUM ION; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHENYLALANYL BETA ALANYLPHENYLALANYLNORLEUCYLBOMBESIN[6-14]; PROTEIN C FOS; RECEPTOR SUBTYPE; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME INHIBITOR INTERACTION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; PEPTIDE ANALYSIS; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION;

BOMBESIN; CALCIUM; DNA-BINDING PROTEINS; ENZYME INHIBITORS; ETS-DOMAIN PROTEIN ELK-1; FLAVONOIDS; GENES, FOS; HUMANS; LUNG NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; ONCOGENES; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; RECEPTORS, BOMBESIN; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0035910373     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00941-9     Document Type: Article

References (40)

1. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
2. Isolation and amino acid sequences of alytesin and bombesin: Two analogous active tetradecapeptides from the skin of European discoglossid frogs
3. Molecular cloning of the bombesin/GRP receptor from Swiss 3T3 cells
4. 3 stimulation of EGR induction
5. Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth
6. Establishment and identification of small cell lung cancer cell lines having classic and variant features
7. Inhibition of v-raf dependent c-fos expression and transformation by a kinase-defective mutant of the MAP kinase Erk2
8. GRP gene expression is stimulated in small cell lung cancer cells by phorbol ester
9. Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells
10. A synthetic inhibitor of the mitogen-activated protein kinase cascade
11. PD165929 - The first high affinity non-peptide neuromedin B (NMB) receptor selective antagonist
12. BRS-3: A novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells
13. Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy
14. Transient activation of RAF-1, MEK and ERK2 coincides kinetically with ternary complex factor and immediate-early gene promoter activity in vivo
15. 2+ sensitive microtubule associate protein 2 kinase
16. Nuclear localization and regulation of erk- and rsk-encoded protein kinases
17. Inhibition of v-raf dependent c-fos expression and transformation by a kinase defective mutant of the mitogen activated protein kinase ERK-2
18. Bombesin activates MAP kinase in non-small cell lung cancer cells
19. 14)Bombesin analogues inhibit the growth of small cell lung cancer in vitro and in vivo
20. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors
21. Bombesin induced behavioral changes: Antagonism by neuroleptics
22. High levels of intracellular bombesin characterize human small-cell lung carcinoma
23. Bombesin-like peptides elevate cytosolic calcium in small cell lung cancer cells
24. BW1023U90: A new GRP receptor probe for small cell lung cancer cells
25. BW2258: A GRP receptor antagonist which inhibits small cell lung cancer growth
26. GRP receptors are present on non-small cell lung cancer cell lines
27. 4)
28. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity
29. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3
30. Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells
31. Growth of small cell lung cancer cells: Stimulation by multiple neuropeptides and inhibition by a broad spectrum antagonists in vitro and in vivo
32. α activated raf-1 by direct phosphorylation
33. Cloning and functional characterization of a cDNA encoding the murine fibroblast bombesin/GRP receptor
34. Activation of the c-raf protein kinase by protein kinase C
35. Pituitary adenylate cyclase activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activation of the mitogen-activated protein kinase (MAP) kinase pathway
36. cDNA cloning, characterization and brain region-specific expression of a neuromedin-B preferring bombesin receptor
37. Oncogenic ras activated c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases
38. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathwaysm
39. 11) substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer
40. Stimulation by bombesin and inhibition by BB-GRP antagonist RC-3095 of growth of human breast cancer cell lines